All Pharma News
Insider trading off Merck-Pandion deal was family affair: SEC

Insider trading off Merck-Pandion deal was family affair: SEC
Max Bayer FIERCEBIOTECH
11 Nov 2022
Share Share
Merck Completes Acquisition of Pandion Therapeutics

Merck Completes Acquisition of Pandion Therapeutics
BUSINESSWIRE
31 Mar 2021
Share Share
Selexis Enters Service Agreement with Pandion Therapeutics to Advance Pandion

Selexis Enters Service Agreement with Pandion Therapeutics to Advance Pandion
BUSINESSWIRE
16 Mar 2021
Share Share
Selexis, Pandion Enter Antibody Service Agreement

Selexis, Pandion Enter Antibody Service Agreement
CONTRACTPHARMA
16 Mar 2021
Share Share
After three years of courtship (& turndowns), Merck pounced on the first glance

After three years of courtship (& turndowns), Merck pounced on the first glance
Amber Tong ENDPTS
06 Mar 2021
Share Share
How Pandion went from a $65M Merck offer to a $1.9B done deal

How Pandion went from a $65M Merck offer to a $1.9B done deal
Ben Adams FIERCEBIOTECH
05 Mar 2021
Share Share
Merck to Acquire Pandion Therapeutics

Merck to Acquire Pandion Therapeutics
BUSINESSWIRE
24 Feb 2021
Share Share
Pandion Presents Preclinical Data Highlighting Potential -Tethered PD-1

Pandion Presents Preclinical Data Highlighting Potential -Tethered PD-1
GLOBENEWSWIRE
22 Feb 2021
Share Share
Pandion Therapeutics Announces Positive Top-Line Ph1a Data Showing PT101

Pandion Therapeutics Announces Positive Top-Line Ph1a Data Showing PT101
GLOBENEWSWIRE
04 Jan 2021
Share Share
Pandion Highlights Potential of Modular Biologics Pipeline for the Treatment

Pandion Highlights Potential of Modular Biologics Pipeline for the Treatment
GLOBENEWSWIRE
28 Oct 2020
Share Share